Total Payments
$11,499
2024 Payments
$1,690
Companies
49
Transactions
520
Medicare Patients
16,734
Medicare Billing
$787,532
Payment Breakdown by Category
Food & Beverage$11,479 (99.8%)
Education$19.90 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,479 | 517 | 99.8% |
| Education | $19.90 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,579 | 112 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,162 | 48 | $0 (2024) |
| Amgen Inc. | $1,121 | 58 | $0 (2024) |
| Lilly USA, LLC | $1,110 | 65 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $983.98 | 23 | $0 (2024) |
| PFIZER INC. | $622.52 | 34 | $0 (2024) |
| ABBVIE INC. | $439.07 | 17 | $0 (2024) |
| Merck Sharp & Dohme LLC | $424.89 | 21 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $390.67 | 13 | $0 (2024) |
| Amarin Pharma Inc. | $286.05 | 12 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,690 | 68 | Lilly USA, LLC ($411.27) |
| 2023 | $1,693 | 79 | Lilly USA, LLC ($287.09) |
| 2022 | $1,872 | 92 | Novo Nordisk Inc ($345.00) |
| 2021 | $1,116 | 51 | Novo Nordisk Inc ($251.80) |
| 2020 | $609.37 | 33 | Amgen Inc. ($122.80) |
| 2019 | $880.20 | 41 | Amgen Inc. ($206.39) |
| 2018 | $1,663 | 69 | Boehringer Ingelheim Pharmaceuticals, Inc. ($263.01) |
| 2017 | $1,976 | 87 | Boehringer Ingelheim Pharmaceuticals, Inc. ($289.03) |
All Payment Transactions
520 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $21.19 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: VACCINE | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.33 | General |
| Category: Biological | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Obesity | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.26 | General |
| Category: Diabetes Care | ||||||
| 09/27/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Obesity | ||||||
| 09/16/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.03 | General |
| Category: DIABETES | ||||||
| 09/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: Diabetes | ||||||
| 09/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: Diabetes | ||||||
| 09/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: PAIN | ||||||
| 08/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.87 | General |
| Category: Diabetes | ||||||
| 08/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $108.96 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/22/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Obesity | ||||||
| 08/20/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: Cardio-renal | ||||||
| 08/19/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $40.27 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 08/15/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: Bone Health | ||||||
| 08/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $23.95 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/30/2024 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $118.86 | General |
| Category: Bone Health | ||||||
| 07/23/2024 | Radius Health, Inc. | — | Food and Beverage | In-kind items and services | $30.12 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 4,268 | 8,568 | $518,986 | $217,851 |
| 2022 | 28 | 4,134 | 8,184 | $492,369 | $198,228 |
| 2021 | 30 | 4,243 | 8,421 | $502,197 | $204,693 |
| 2020 | 27 | 4,089 | 7,442 | $440,148 | $166,760 |
Total Patients
16,734
Total Services
32,615
Medicare Billing
$787,532
Procedure Codes
116
All Medicare Procedures & Services
116 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 380 | 742 | $129,850 | $62,737 | 48.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 25 | 2,700 | $108,000 | $49,444 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 236 | 236 | $35,400 | $30,366 | 85.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 131 | 191 | $22,920 | $11,090 | 48.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 413 | 832 | $12,480 | $6,981 | 55.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 93 | 93 | $8,649 | $6,618 | 76.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 338 | 391 | $25,415 | $6,436 | 25.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 356 | 455 | $28,665 | $5,958 | 20.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 391 | 575 | $25,300 | $5,942 | 23.5% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 310 | 323 | $20,349 | $4,774 | 23.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 332 | 457 | $28,334 | $4,326 | 15.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 14 | 14 | $7,910 | $3,960 | 50.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 387 | 510 | $16,320 | $3,881 | 23.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 17 | 17 | $3,060 | $2,815 | 92.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 90 | 90 | $4,320 | $2,722 | 63.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 67 | 68 | $6,120 | $1,973 | 32.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 14 | $3,304 | $1,762 | 53.3% |
| 81003 | Automated urinalysis test | Office | 2023 | 363 | 456 | $13,224 | $999.30 | 7.6% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 21 | 25 | $2,750 | $869.60 | 31.6% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 41 | 41 | $2,788 | $775.72 | 27.8% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 27 | 35 | $2,380 | $630.70 | 26.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 25 | 52 | $2,340 | $579.80 | 24.8% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 40 | 56 | $1,680 | $464.24 | 27.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 13 | 13 | $624.00 | $393.12 | 63.0% |
| 83550 | Iron binding capacity | Office | 2023 | 23 | 32 | $960.00 | $274.24 | 28.6% |
About Dr. Drue Ferrante, MD
Dr. Drue Ferrante, MD is a Internal Medicine healthcare provider based in Gainesville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/16/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265427165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Drue Ferrante, MD has received a total of $11,499 in payments from pharmaceutical and medical device companies, with $1,690 received in 2024. These payments were reported across 520 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($11,479).
As a Medicare-enrolled provider, Ferrante has provided services to 16,734 Medicare beneficiaries, totaling 32,615 services with total Medicare billing of $787,532. Data is available for 4 years (2020–2023), covering 116 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Gainesville, FL
- Active Since 09/16/2005
- Last Updated 06/26/2013
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1265427165
Products in Payments
- JARDIANCE (Drug) $1,084
- FARXIGA (Drug) $911.64
- Ozempic (Drug) $606.51
- EVENITY (Biological) $578.58
- ELIQUIS (Drug) $492.95
- MOUNJARO (Drug) $469.34
- Kerendia (Drug) $390.67
- NURTEC ODT (Drug) $386.17
- Rybelsus (Drug) $354.33
- Vascepa (Drug) $286.05
- BELSOMRA (Drug) $262.42
- Wegovy (Drug) $260.74
- VRAYLAR (Drug) $260.09
- TRULICITY (Drug) $238.11
- Repatha (Biological) $215.90
- Tymlos (Biological) $177.04
- Victoza (Drug) $158.13
- Cook Medical Zilver PTX (Device) $155.21
- Dayvigo (Drug) $138.54
- VOQUEZNA (Drug) $136.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Gainesville
Dr. Vivek Sambhara, M.d, M.D
Internal Medicine — Payments: $217,213
Internal Medicine $217,213
Dr. Christopher Recknor, M.d, M.D
Internal Medicine — Payments: $91,144
Internal Medicine $91,144
Dr. Carlos Alviar Restrepo, Md, MD
Internal Medicine — Payments: $90,926
Internal Medicine $90,926
Dr. Alanna Morris, M.d, M.D
Internal Medicine — Payments: $85,602
Internal Medicine $85,602
Brian Ramnaraign, M.d, M.D
Internal Medicine — Payments: $65,740
Internal Medicine $65,740
Ilie Barb, M.d, M.D
Internal Medicine — Payments: $55,024
Internal Medicine $55,024